Clinical Trial Update: Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis [NA]

View source ↗

Summary

Clinical trial update discussing the efficacy and safety of Firsekibart in treating systemic sclerosis, with the study status showing NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Firsekibart

Snippet

Sponsor: Tongji Hospital | Conditions: Systemic Scleroderma | NA | Status: NOT_YET_RECRUITING